Epigenetic alteration by DNA-demethylating treatment restores apoptotic response to glucocorticoids in dexamethasone-resistant human malignant lymphoid cells

BACKGROUND: Glucocorticoids (GCs) are often included in the therapy of lymphoid malignancies because they kill several types of malignant lymphoid cells. GCs activate the glucocorticoid receptor (GR), to regulate a complex genetic network, culminating in apoptosis. Normal lymphoblasts and many lymph...

Descripción completa

Detalles Bibliográficos
Autores principales: Miller, Aaron L, Geng, Chuandong, Golovko, Georgiy, Sharma, Meenakshi, Schwartz, Jason R, Yan, Jiabin, Sowers, Lawrence, Widger, William R, Fofanov, Yuriy, Vedeckis, Wayne V, Thompson, E Brad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4008436/
https://www.ncbi.nlm.nih.gov/pubmed/24795534
http://dx.doi.org/10.1186/1475-2867-14-35

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4008436/
https://www.ncbi.nlm.nih.gov/pubmed/24795534
http://dx.doi.org/10.1186/1475-2867-14-35

Ejemplares similares